Template:Saphenous vein graft: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 40: | Line 40: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Saphenous | [[Saphenous Vein Graft Nomenclature|Nomenclature]] | ||
|- | |- | ||
! | ! | ||
Line 46: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Pathophysiology of | [[Pathophysiology of Saphenous Vein Graft Disease|Pathophysiology]] | ||
|- | |- | ||
! | ! | ||
Line 52: | Line 52: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Assessment of | [[Assessment of Target Vessels for Saphenous Vein Grafting|Assesment of Vessels]] | ||
|- | |- | ||
! | ! | ||
Line 58: | Line 58: | ||
|- bgcolor="CornFlowerBlue" | |- bgcolor="CornFlowerBlue" | ||
! | ! | ||
Diagnosis | Diagnosis and Evaluation of SVG Disease | ||
|- | |- | ||
! | ! | ||
Line 64: | Line 64: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Symptoms of | [[Symptoms of SVG Occlusion|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
Line 70: | Line 70: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Chest | [[Chest X-Ray in the Patient with Saphenous Vein Grafts|Chest X Ray]] | ||
|- | |- | ||
! | ! | ||
Line 76: | Line 76: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[CT | [[CT Angiography in the Assessment of Saphenous Vein Graft Disease|CT]] | ||
|- | |- | ||
! | ! | ||
Line 82: | Line 82: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Cardiac | [[Cardiac Catheterization|Cardiac Catheterization]] | ||
|- | |- | ||
! | ! | ||
Line 88: | Line 88: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Saphenous | [[Saphenous Vein Graft Pathology|Pathology]] | ||
|- | |- | ||
! | ! | ||
Line 94: | Line 94: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Definition of | [[Definition of Saphenous Vein Graft Failure|Definition]] | ||
|- | |- | ||
! | ! | ||
Line 100: | Line 100: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Historical | [[Historical Rates of Saphenous Vein Graft Failure|Historical Rates of Saphenous Vein Graft Failure]] | ||
|- | |- | ||
! | ! | ||
Line 106: | Line 106: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Determinants of | [[Determinants of Sapheous Vein Graft Patency|Determinants of Sapheous Vein Graft Patency]] | ||
|- | |- | ||
! | ! | ||
Line 112: | Line 112: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Saphenous vein graft failure as a | [[Saphenous vein graft failure as a Surrogate Endpoint in Clinical Trials|Saphenous vein graft failure as a Surrogate Endpoint in Clinical Trials]] | ||
|- | |- | ||
! | ! |
Revision as of 19:37, 25 October 2012
Saphenous vein graft Microchapters |
Diagnosis and Evaluation of SVG Disease |
---|
Saphenous vein graft failure as a Surrogate Endpoint in Clinical Trials |
Treatment |
Saphenous vein graft On the Web |
American Roentgen Ray Society Images of Saphenous vein graft |